In vivo, CuB reduced tumor growth and metastasis, enhanced CD8+ and CD4+ T cell infiltration, and reduced regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs). Here, CD8A is linked to neoplasm.